Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 669 | 676 | 610 | 610 | 640 |
| Gross Profit | 669 | 676 | 610 | 610 | 640 |
| Operating Expenses | 10,104 | 8,749 | 9,140 | 10,603 | 10,504 |
| Operating Income | -9,435 | -8,073 | -8,530 | -9,993 | -9,864 |
| Interest Expense | 484 | 474 | 473 | 476 | 298 |
| Other Income | 85 | 10 | 49 | 23 | 76 |
| Pre-tax Income | -9,834 | -8,537 | -8,954 | -10,446 | -10,086 |
| Net Income Continuous | -9,834 | -8,537 | -8,954 | -10,446 | -10,086 |
| Net Income | $-9,834 | $-8,537 | $-8,954 | $-10,446 | $-10,086 |
| EPS Basic Total Ops | -16.45 | -13.30 | -21.70 | -25.20 | -24.50 |
| EPS Basic Continuous Ops | -16.37 | -13.55 | -21.61 | -25.23 | -24.44 |
| EPS Diluted Total Ops | -16.45 | -13.30 | -21.70 | -25.20 | -24.50 |
| EPS Diluted Continuous Ops | -16.37 | -13.55 | -21.61 | -25.23 | -24.44 |
| EBITDA(a) | $-9,355 | $-7,991 | $-8,449 | $-9,911 | $-9,739 |